Mesenteric venous thrombosis in hereditary protein C deficiency with the mutation at Arg169 (CGG→TGG)

Internal Medicine

Volumn 42, Issue 1, 2003, Pages 110-116

  Momoi, Atsuko ^a   Komura, Yasuo ^a   Kumon, Izumi ^a   Tamai, Masatake ^a   Tarumi, Yoshinao ^a   Matsubara, Jun ^a   Miyauchi, Kagen ^a   Yamanouchi, Jun ^b   Hato, Takaaki ^b  

^a Musculoskeletal Tumor Surgery Center   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Congenital hypercoagulable disorder; MVT; Protein C deficiency; Thrombolytic therapy

Indexed keywords

ANTICOAGULANT AGENT; ARGININE; CYTOSINE; GUANINE; HEPARIN; PEPTIDE; PROTEIN C; PROTHROMBIN; THROMBOPLASTIN; THYMINE; UROKINASE; WARFARIN;

ABDOMINAL PAIN; ADULT; AMINO ACID SEQUENCE; ANAMNESIS; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CODON; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; GENE MUTATION; GENETIC DISORDER; HETEROZYGOSITY; HOSPITAL ADMISSION; HUMAN; ILEUS; INTESTINE NECROSIS; INTESTINE STENOSIS; LAPAROTOMY; MALE; MELENA; MESENTERIC VEIN THROMBOSIS; PROTEIN C DEFICIENCY; PROTEIN DEGRADATION; SEQUENCE ANALYSIS; SUPERIOR MESENTERIC VEIN; SYMPTOMATOLOGY;

EID: 0037288694     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.110     Document Type: Article

References (34)

1. Warren S, Eberhard TP. Mesenteric venous thrombosis. Surg Gynecol Obstet 61: 102-121, 1935.
2. Abdu RA, Zakbour BJ, Dallis DJ. Mesenteric venous thrombosis-1911 to 1984. Surgery 101: 383-388, 1987.
3. Harward TR, Green D, Bergan JJ, Rizzo RJ, Yao JS. Mesenteric venous thrombosis. J Vasc Surg 9: 328-333, 1989.
4. Choudhary AM, Grayer D, Nelson A, Roberts I. Mesenteric venous thrombosis: a diagnosis not to be missed! J Clin Gastroenterol 31: 179-182, 2000.
5. Kitchens CS. Evolution of our understanding of the pathophysiology of primary mesenteric venous thrombosis. Am J Surg 163: 346-348, 1992.
6. Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med 345: 1683-1688, 2001.
7. Wilson C, Walker ID, Davidson JF, Imrie CW. Mesenteric venous thrombosis and antithrombin III deficiency. J Clin Pathol 40: 906-908, 1987.
8. Engesser L, Broekmans AW, Briet E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 106: 677-682, 1987.
9. Broekmans AW, van Rooyen W, Westerveld BD, Briet E, Bertina RM. Mesenteric vein thrombosis as presenting manifestation of hereditary protein S deficiency. Gastroenterology 92: 240-242, 1987.
10. Orozco H, Guraieb E, Takahashi T, et al. Deficiency of protein C in patients with portal vein thrombosis. [see comments] Hepatology 8: 1110-1111, 1988.
11. Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 82: 1121-1125, 1985.
12. van Hinsbergh VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 65: 444-451, 1985.
13. Sakata Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin JH. Mechanism of protein C-dependent clot lysis: Role of plasminogen activator inhibitor. Blood 68: 1218-1223, 1986.
14. De Stefano V, Leone G, Mastrangelo S, et al. Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 72: 352-358, 1994.
15. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: A prospective cohort study. Thromb Haemost 71: 441-445, 1994.
16. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. [see comments] Blood 87: 3531-3544, 1996.
17. Elliot JW. The operative relief of gangrene of the intestine due to occlusion of the mesenteric vessels. Ann Surg 21: 9-23, 1895.
18. Poplausky MR, Kaufman JA, Geller SC, Waltman AC. Mesenteric venous thrombosis treated with urokinase via the superior mesenteric artery. Gastroenterology 110: 1633-1635, 1996.
19. Yajima Y, Miyasato S, Miyazaki A, Eda Y, Shibuya D, Oohira S. A case of portal and superior mesenteric thrombosis associated with protein S deficiency treated with urokinase via the superior mesenteric vein. Jpn J Gastroenterol 96: 1159-1164, 1999 (in Japanese).
20. Robin P, Gruel Y, Lang M, Lagarrigue F, Scotto JM. Complete thrombolysis of mesenteric vein occlusion with recombinant tissue-type plasminogen activator. [letter] Lancet 1: 1391, 1988.
21. Mitani M, Kuwabara Y, Kawamura H, Sato A, Hattori K, Fujii Y. Mesenteric venous thrombosis associated with protein C deficiency. J Gastroenterol 34: 387-389, 1999.
22. Yates P, Cumber PM, Sanderson S, Harrison BJ. Mesenteric venous thrombosis due to protein C deficiency. Clin Lab Hematol 13: 137-139, 1991.
23. Miletich J, Sherman L, Broze G Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 317: 991-996, 1987.
24. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 73: 87-93, 1995.
25. Sakata T, Kario K, Katayama Y, Matsuyama T, Kato H, Miyata T. Studies on congenital protein C deficiency in Japanese: prevalence, genetic analysis, and relevance to the onset of arterial occlusive diseases. Semin Thromb Hemost 26: 11-16, 2000.
26. Pabinger I, Schneider B, and the GTH Group on Natural Inhibitors. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Arterioscler Thromb Vasc Biol 16: 742-748, 1996.
27. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. [see comments] Lancet 341: 134-138, 1993.
28. De Stefano V, Mastrangelo S, Schwarz HP, et al. Replacement therapy with a purified protein C concentrate during initiation of oral anticoagulation in severe protein C congenital deficiency. Thromb Haemost 70: 247-249, 1993.
29. Mainwaring CJ, Makris M, Thomas WE, Hampton KK, Preston FE. Mesenteric infarction due to combined protein C deficiency and prothrombin 20210 defects. Postgrad Med J 75: 742-743, 1999.
30. Kisiel W. Human plasma protein C: Isolation, characterization and mechanism of activation by alpha-thrombin. J Clin Invest 64: 761-769, 1979.
31. Dahlback B. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis. Thromb Res 77: 1-43, 1995.
32. Matsuda M, Sugo T, Sakata Y, et al. A thrombotic state due to an abnormal protein C. N Engl J Med 319: 1265-1268, 1988.
33. Miyata T, Sakata T, Yasumuro Y, et al. Genetic analysis of protein C deficiency in nineteen Japanese families: five recurrent defects can explain half of the deficiencies, Thromb Res 92: 181-187, 1998.
34. Ohwada A, Takahashi H, Uchida K, Nukiwa T, Kira S. Gene analysis of heterozygous protein C deficiency in a patient with pulmonary arterial thromboembolism. Am Rev Respir Dis 145: 1491-1494, 1992.